Interventional oncology in children: Where are we now?
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel +1 more
wiley +1 more source
Papillary Thyroid Carcinoma in a Branchial Cleft Cyst: A Two-Case Single-Center Experience. [PDF]
Ferreira A +4 more
europepmc +1 more source
The Roles of EDA2R in Ageing and Disease
Elevated expression of the ectodysplasin A2 receptor (EDA2R) has been linked to ageing and disease. We appraise the roles of EDA2R in these processes, exploring mechanisms of action, biomarker potential and therapeutic relevance of EDA2R in multiple contexts. ABSTRACT Ageing is a complex biological process driven, in part, by inflammaging.
Gemma Farrington +9 more
wiley +1 more source
Multifocal Medullary and Papillary Thyroid Carcinoma Occurring as a Collision Tumor: A Case Report. [PDF]
Gadre S +4 more
europepmc +1 more source
ABSTRACT Over 5000 patients are newly diagnosed with Alopecia areata (AA) in Australia each year. AA severity varies from a single small patch to complete loss of scalp hair, body hair including eyelashes and eyebrows. Approximately 40% of affected individuals experience only a single patch and achieve spontaneous, complete and durable remission within
Daniella Kushnir‐Grinbaum +19 more
wiley +1 more source
Choroidal metastases and exudative retinal detachment in medullary thyroid carcinoma. [PDF]
Shukla A +3 more
europepmc +1 more source
Correction: Predictive factors for failure in patients with N1b papillary thyroid carcinoma. [PDF]
Margulis I, Gordon Y, Stein N, Doweck I.
europepmc +1 more source
A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer [PDF]
Baranski, Thomas +8 more
core +1 more source
This secondary analysis of the MAESTRO‐NASH trial examined the effects of resmetirom in patients with weight loss and/or treated with therapies for T2D. The efficacy of resmetirom was not impacted by background T2DM therapies. Weight loss (≥ 5%) enhanced the effect of resmetirom on multiple MASH endpoints. ABSTRACT Background MAESTRO‐NASH, a randomised,
Mazen Noureddin +7 more
wiley +1 more source
Papillary thyroid carcinoma with metastasis to the femur as a rare cause of femoral fracture: A case report. [PDF]
Chen J, Zhang M.
europepmc +1 more source

